The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation

M Mohty, RF Duarte, S Croockewit, K Hübel… - Leukemia, 2011 - nature.com
High-dose chemotherapy with or without radiation therapy is an effective treatment strategy
for patients with non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and Hodgkin's …

[HTML][HTML] Effect of total nucleated and CD34+ cell dose on outcome after allogeneic hematopoietic stem cell transplantation

M Remberger, J Törlén, O Ringdén, M Engström… - Biology of Blood and …, 2015 - Elsevier
During more recent years only few studies have analyzed the effect of total nucleated cell
(TNC) and CD34+ cell dose in allogeneic hematopoietic stem cell transplantation (HSCT). A …

Flow cytometric characterization of hematopoietic stem and progenitor cell subpopulations in autologous peripheral blood stem cell preparations after …

A Heuer, S Löwhagen, S Uhlig, S Hetjens… - Transfusion Medicine …, 2023 - karger.com
Introduction: Autologous stem cell transplantation is a successful routine procedure with only
a small number of non-engraftment cases, although the time to hematopoietic recovery may …

Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources

J Dmytrus, S Matthes-Martin, H Pichler… - Bone marrow …, 2016 - nature.com
Flow cytometric routine CD34 analysis enumerates hematopoietic stem and progenitor cells
irrespective of their subpopulations although this might predict engraftment dynamics and …

Nomogram for predicting early mortality after umbilical cord blood transplantation in children with inborn errors of immunity

P Wang, C Liu, Z Wei, W Jiang, H Sun, Y Wang… - Journal of Clinical …, 2023 - Springer
Purpose Pediatric patients with inborn errors of immunity (IEI) undergoing umbilical cord
blood transplantation (UCBT) are at risk of early mortality. Our aim was to develop and …

[HTML][HTML] Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma

K Chen, H Liang, Z Yu, G Guo, H Zheng, Y Huang… - Scientific Reports, 2025 - nature.com
This retrospective study aimed to stress the advantages of autologous hematopoietic stem
cell transplantation (auto-HSCT) in treating primary MM. Ninety-four MM patients who …

Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation

MQ Salas, EG Atenafu, MR Bautista… - European Journal of …, 2020 - Wiley Online Library
Objectives Haploidentical hematopoietic stem cell transplant (haplo‐SCT) has been
associated with higher rates of graft rejection, and a higher dose of CD34+ cell dose is …

[HTML][HTML] Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation

AK Singh, BN Savani, PS Albert, AJ Barrett - Biology of Blood and Marrow …, 2007 - Elsevier
We estimated the effect of CD34+ stem cell dose during peripheral blood stem cell
transplantation (PBSCT) in predicting mortality after total body irradiation (TBI). Between …

[HTML][HTML] Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation

MJ Ninan, CR Flowers, JD Roback, ML Arellano… - Biology of Blood and …, 2007 - Elsevier
The frequency and clinical significance of secondary thrombocytopenia following initial
engraftment in autologous hematopoietic progenitor cell transplantation (HPCT) is unknown …

Effects of CD34+ cell dose on engraftment and long‐term outcomes after allogeneic bone marrow transplantation

T Oyama, S Fujiwara, R Tominaga… - Clinical …, 2024 - Wiley Online Library
Background The number of CD34+ cells in the graft is generally associated with time to
engraftment and survival in transplantation using cord blood or allogeneic peripheral blood …